A former insider says named Trump aides steered health policy for donors—and he points to a vaccine ask as proof.
Story Snapshot
- Calley Means went on record naming officials he says blocked Make America Healthy Again goals.
- He alleges a quid pro quo tying approval of Moderna’s mRNA flu shot to other policy help.
- Susie Wiles, James Blair, and Continental Strategy deny key claims; the White House disputes them.
- Attorney General Todd Blanche rejects the need for a Justice Department probe.
The on-record allegations and the policy choke points
Calley Means, a former senior adviser and one-time aide to Robert F. Kennedy Jr., accused specific Trump officials of tilting health policy toward donors. He named Susie Wiles and deputy James Blair in efforts he says pushed a pathway for fruit-flavored vapes. He called White House official Brian O’Connor the biggest obstacle to Make America Healthy Again plans at Health and Human Services. He made these claims on national television and a long-form podcast, placing dates and names on the record.
Means says the choke points sat where politics meets science. He alleges that vape policy, children’s sugar research, and drug approvals ran into private asks and gatekeeping. He claims Wiles-linked networks offered access that companies could pay for, routing through family and allied firms. The New York Sun summarized his claim that Wiles and her daughter, Katie, opened doors for food and drug clients. That picture suggests soft power more than signed orders—the kind that is hard to see but easy to feel.
The vaccine quid pro quo claim at the center
Means pointed to a specific meeting. He says Brian O’Connor told Health and Human Services Secretary Marty Makary that broader cooperation would follow only if he approved Moderna’s mRNA flu vaccine, branded mFLUSIVA. Means adds that Makary believed the science did not support approval at that time. If accurate, that is not a policy debate; that is leverage. No transcript or corroborating record has surfaced in the reporting available so far. One allegation does not equal proof, but a named exchange welcomes scrutiny.
The stakes around this claim are clear. The Food and Drug Administration must judge safety and efficacy, not politics. A conditional ask tied to another policy would break the frame that keeps science first. A conservative view favors limited government but firm lines on integrity. If an aide linked unrelated approvals to cooperation, that would cross a line. If not, then this is a hard-edged but normal fight over priorities. The difference rests in records we have not yet seen.
Pushback from the administration and named officials
Susie Wiles denies arranging meetings between tobacco representatives and President Trump about vape policy. James Blair says he did not promote flavored vapes. Continental Strategy, speaking for Katie Wiles, calls Means’s claims false and says it did not lobby for vapes, kratom, glyphosate, Monsanto, or Bayer. The White House disputes Means’s narrative. These are clear, specific denials, and they put the burden on documents, timelines, and witnesses to break the tie.
🚨 DID TRUMP’S OWN WHITE HOUSE INSIDERS UNDERMINE THE MAGA AND MAHA AGENDA?
Former Trump adviser Calley Means is making explosive accusations against Susie Wiles and the political operatives surrounding President Trump.
Speaking with Joe Rogan, Means alleged that corporate…
— MDBayNews (@MDBayNews) November 7, 2026
Attorney General Todd Blanche dismissed the allegations as a faction fight that does not merit Department of Justice action. He said he strongly disagrees that Wiles put other priorities ahead of President Trump and that her financial dealings do not concern him. That stance sets a high bar for formal inquiry. It also signals confidence that no paper trail will contradict the denials. If evidence exists, it should surface; if not, the claims will fade as political drama, not a policy breach.
What evidence would settle this fast
Calendars, visitor logs, and emails would show who met whom, about what, and when. Food and Drug Administration review files and Health and Human Services notes would reveal whether mFLUSIVA followed normal approval standards or jumped the line. Drafts and routing slips on children’s sugar policy would show meaningful delay or edits tied to donor talks. Lobbying registrations, contracts, and invoices would test the alleged access-for-pay channel. One verified memo could change the whole story—or close it.
How to read this through a conservative lens
Healthy skepticism is not cynicism. Big industries lobby hard; that is a fact of life. Government’s job is to draw bright lines, publish processes, and keep science separate from political favors. Conservatives should want small, clean government that does not sell access, and strong civil society that holds officials to account. If Means is right, then transparency fixes the rot. If he is wrong, then sunlight still helps, because open records will clear the air without show trials or leaks.
Sources:
cbsnews.com, axios.com, nysun.com
